Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Shiun Chen

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|July 1, 2020
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled TrialLi-Shiun Chen, Timothy B Baker, J Philip Miller, et al.
Annals of the American Thoracic Society|July 30, 2014
Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxideA Joseph Bloom, Sarah M Hartz, Timothy B Baker, et al.
Chest|December 17, 2021
The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer ResectionBrendan T Heiden, Daniel B Eaton, Su-Hsin Chang, et al.
Annals of Surgery|November 18, 2021
Assessment of Duration of Smoking Cessation Prior to Surgical Treatment of Non-small Cell Lung CancerBrendan T Heiden, Daniel B Eaton, Su-Hsin Chang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 13, 2017
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and HowLi-Shiun Chen, Laurie Zawertailo, Thomas M Piasecki, et al.
Biological Psychiatry|July 26, 2017
Association Between Substance Use Disorder and Polygenic Liability to SchizophreniaSarah M Hartz, Amy C Horton, Mary Oehlert, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2017
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic FindingsNancy L Saccone, James W Baurley, Andrew W Bergen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 15, 2021
Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected CohortMichael J Bray, Li-Shiun Chen, Louis Fox, et al.
The American Journal of Psychiatry|June 1, 2012
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation successLi-Shiun Chen, Timothy B Baker, Megan E Piper, et al.
Journal of Clinical and Translational Science|June 18, 2025
Patient-generated health data: Impact on promoting patient-centered point of care tobacco treatment in patients with cancerJessica Liu, Timothy B Baker, Jingling Chen, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|July 1, 2020
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled TrialLi-Shiun Chen, Timothy B Baker, J Philip Miller, et al.
Annals of the American Thoracic Society|July 30, 2014
Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxideA Joseph Bloom, Sarah M Hartz, Timothy B Baker, et al.
Chest|December 17, 2021
The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer ResectionBrendan T Heiden, Daniel B Eaton, Su-Hsin Chang, et al.
Annals of Surgery|November 18, 2021
Assessment of Duration of Smoking Cessation Prior to Surgical Treatment of Non-small Cell Lung CancerBrendan T Heiden, Daniel B Eaton, Su-Hsin Chang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 13, 2017
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and HowLi-Shiun Chen, Laurie Zawertailo, Thomas M Piasecki, et al.
Biological Psychiatry|July 26, 2017
Association Between Substance Use Disorder and Polygenic Liability to SchizophreniaSarah M Hartz, Amy C Horton, Mary Oehlert, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2017
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic FindingsNancy L Saccone, James W Baurley, Andrew W Bergen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 15, 2021
Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected CohortMichael J Bray, Li-Shiun Chen, Louis Fox, et al.
The American Journal of Psychiatry|June 1, 2012
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation successLi-Shiun Chen, Timothy B Baker, Megan E Piper, et al.
Journal of Clinical and Translational Science|June 18, 2025
Patient-generated health data: Impact on promoting patient-centered point of care tobacco treatment in patients with cancerJessica Liu, Timothy B Baker, Jingling Chen, et al.
Pageof 10